Filter By Category
Archives
Share on -
EFARINDODEKIN ALFA
Generic Name: EFARINDODEKIN ALFA
ABSTRACT -
Efarindodekin alfa is a recombinant cytokine/interleukin-family biologic. Its safety and activity depend on receptor selectivity and immune-cell activation profile.
DOSAGE -
Protocol-specific dosing only, commonly SC/IV in microgram or weight-based units.
SIDE EEFECTS -
- Fever, chills, or flu-like symptoms
- Injection-site reaction
- Fatigue
- Hypotension or capillary-leak-type symptoms
- Liver-enzyme or hematologic changes
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Rash, urticaria, dyspnea, hypotension, or anaphylaxis
DRUG INTEACTIONS-
- Other cytokines/checkpoint inhibitors may increase immune toxicity
- Immunosuppressants may blunt efficacy
- Live vaccines require review
PREAUTONS–
- Monitor vital signs, CBC, liver tests, inflammatory markers, and autoimmune symptoms
- Use caution in severe cardiovascular disease or active autoimmune disease
- Pregnancy safety not established
WARNINGS –
- Cytokine-mediated toxicity, capillary leak, autoimmune activation, and hypersensitivity may occur
Share on -
. Developed by